Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._1 type RangedSequencePosition NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw.assertion.
- NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._1 type SO_0001148 NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw.assertion.
- NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._1 comment "Does not inhibit interaction with MAP3K5. Does not reduce GSK3B-induced beta-catenin transcription activity, TNF-alpha-induced apoptosis, ARF6-mediated TLR4-TIRAP-MyD88 signaling inhibition, Ras and NF-kappa-B activities and tumor development. Does not suppress tumor development; when associated with A-728." NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw.assertion.
- NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._1 SIO_000053 NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._2 NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw.assertion.
- NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._1 SIO_000053 NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw._3 NX_Q5VWQ8-5_MUTAGEN_385_385.RAxiD0Ht01E-bsIbx0oB8pSrKvjC5SmB-__jAjKXcBvcw.assertion.